Oramed Pharmaceuticals Inc (NASDAQ:ORMP)
| 3.97 Delayed Data As of Jun 06 |  -0.10 / -2.46%Today’s Change | 1.81 Today|||52-Week Range 13.73 | -67.00% Year-to-Date |
Latest ORMP News | Press Releases
No recent news for Oramed Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.07 |
| Today’s open | 4.05 |
| Day’s range | 3.76 - 4.05 |
| Volume | 45,603 |
| Average volume (3 months) | 1,041,337 |
| Market cap | $160.9M |
Data as of 3:59pm ET, 06/06/2023
Growth & Valuation
| Earnings growth (last year) | -20.02% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 173.56 |
| Price/Book | 1.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Ecogreen Internation... | 0.00 | 0.00% |
| PBYIPuma Biotechnology I... | -0.02 | -0.56% |
| ---- | ||
| CRVSCorvus Pharmaceutica... | +0.16 | +4.88% |
Data as of 3:59pm ET, 06/06/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $2.7M |
| Annual profit (last year) | -$36.6M |
| Net profit margin | -1,352.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
